Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.4048
-0.1035 (-20.36%)
Mar 31, 2025, 2:30 PM EDT - Market open

Sensei Biotherapeutics Statistics

Total Valuation

SNSE has a market cap or net worth of $10.18 million. The enterprise value is -$24.71 million.

Market Cap 10.18M
Enterprise Value -24.71M

Important Dates

The last earnings date was Friday, March 28, 2025, before market open.

Earnings Date Mar 28, 2025
Ex-Dividend Date n/a

Share Statistics

SNSE has 25.15 million shares outstanding. The number of shares has decreased by -10.14% in one year.

Current Share Class 25.15M
Shares Outstanding 25.15M
Shares Change (YoY) -10.14%
Shares Change (QoQ) +0.08%
Owned by Insiders (%) 2.23%
Owned by Institutions (%) 9.40%
Float 16.52M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.33
P/TBV Ratio 0.33
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.70, with a Debt / Equity ratio of 0.10.

Current Ratio 7.70
Quick Ratio 7.59
Debt / Equity 0.10
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -351.81

Financial Efficiency

Return on equity (ROE) is -58.40% and return on invested capital (ROIC) is -34.92%.

Return on Equity (ROE) -58.40%
Return on Assets (ROA) -33.06%
Return on Invested Capital (ROIC) -34.92%
Return on Capital Employed (ROCE) -79.33%
Revenue Per Employee n/a
Profits Per Employee -$1.08M
Employee Count 28
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -61.90% in the last 52 weeks. The beta is 0.15, so SNSE's price volatility has been lower than the market average.

Beta (5Y) 0.15
52-Week Price Change -61.90%
50-Day Moving Average 0.47
200-Day Moving Average 0.54
Relative Strength Index (RSI) 41.28
Average Volume (20 Days) 8,071,800

Short Selling Information

The latest short interest is 121,029, so 0.48% of the outstanding shares have been sold short.

Short Interest 121,029
Short Previous Month 146,655
Short % of Shares Out 0.48%
Short % of Float 0.73%
Short Ratio (days to cover) 1.42

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -31.66M
Pretax Income -29.67M
Net Income -30.16M
EBITDA -30.34M
EBIT -31.66M
Earnings Per Share (EPS) -$1.20
Full Income Statement

Balance Sheet

The company has $41.34 million in cash and $3.85 million in debt, giving a net cash position of $37.49 million or $1.49 per share.

Cash & Cash Equivalents 41.34M
Total Debt 3.85M
Net Cash 37.49M
Net Cash Per Share $1.49
Equity (Book Value) 38.39M
Book Value Per Share 1.52
Working Capital 36.48M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$24.67 million and capital expenditures -$146,000, giving a free cash flow of -$24.82 million.

Operating Cash Flow -24.67M
Capital Expenditures -146,000
Free Cash Flow -24.82M
FCF Per Share -$0.99
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SNSE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 10.14%
Shareholder Yield n/a
Earnings Yield -235.89%
FCF Yield -194.11%

Analyst Forecast

The average price target for SNSE is $4.25, which is 949.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.25
Price Target Difference 949.90%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -13.50%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1